Treatment of rheumatoid arthritis with the dopamine agonist quinagolide

J Rheumatol. 1999 Oct;26(10):2284-5.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aminoquinolines / adverse effects
  • Aminoquinolines / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / metabolism
  • Dopamine Agonists / adverse effects
  • Dopamine Agonists / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prolactin / metabolism
  • Treatment Outcome

Substances

  • Aminoquinolines
  • Dopamine Agonists
  • quinagolide
  • Prolactin